Clinical Trial: NI-0801 in Allergic Contact Dermatitis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Proof-of-Principle Study Investigating the Effect of Single Doses of NI-0801 on Nickel Induced Contact Dermatitis
Brief Summary: The purpose of the study is to assess the effect of a single dose of NI-0801 on the severity of nickel-induced allergic contact dermatitis.
Detailed Summary:
Sponsor: NovImmune SA
Current Primary Outcome: Effect of NI-0801 administration on the severity of the cutaneous response to Nickel challenge as measured using the score system of the DKG (Deutsche Kontakt-Allergie Gruppe).
Original Primary Outcome: Same as current
Current Secondary Outcome: Safety and tolerability of NI-0801 as measured by the incidence and severity of treatment emergent adverse events.
Original Secondary Outcome: Same as current
Information By: NovImmune SA
Dates:
Date Received: November 16, 2010
Date Started:
Date Completion:
Last Updated: November 18, 2010
Last Verified: November 2010